[ad_1]
Pfizer and Moderna, which developed the COVID-19 vaccine, used new technology. It will allow you to quickly produce a large number of doses.
The new and revolutionary vaccine also lies in its high efficacy. This was announced by biologist-geneticist Alexander Kolyada on the air of the Freedom of Speech program.
Pay Attention Will Russian COVID-19 Vaccine Be Used In Ukraine: Stepanov’s Response?
What is the revolutionary nature of the vaccine?
According to him, 95% is a difficult level to reach with conventional vaccines:
- bark;
- of tuberculosis;
- seasonal flu.
The COVID-19 vaccine is approximately 40-50% effective.
New technology
The new technology will allow the rapid production of a large number of doses of the drug.
Eliminates a number of risks associated with the need to work with a virus. We need to have laboratories where viruses are grown. It allows you to go to the level of chemistry, that is, to do everything faster, like in a factory,
– said Kolyada.
He also noted that vaccine development is no longer a biological and medical process, but more technical.
What feature
The peculiarity of the vaccine is that it must be injected not with an ordinary injection into the skin, but to deliver the drug into the cell. “One of the companies is considering the option of special devices that should be in each handling room. This will be the same shoulder inoculation that we are used to, but using more complicated technology, ”said the geneticist.
He clarified that the device is inexpensive and is a modified version of the syringe.
